Register Cart 0

Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back Subscribe

Editorial [ Hot Topic: Drugs Targets in Parkinson's Disease:Where Are We and Where should We Go? (Guest Editor: Mark R. Cookson)]

Author(s): Mark R. Cookson

Volume 10, Issue 6, 2011

Page: [650 - 650] Pages: 1

DOI: 10.2174/187152711797247830

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

12

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Non-Antidepressant Treatment of Generalized Anxiety Disorder
Current Clinical Pharmacology

The Applications of Pharmacogenomics to Neurological Disorders
Current Molecular Medicine

Nitric Oxide Modulation of the Basal Ganglia Circuitry: Therapeutic Implication for Parkinson's Disease and Other Motor Disorders
CNS & Neurological Disorders - Drug Targets

A Critical Evaluation of Adenosine A2A Receptors as Potentially “Druggable” Targets in Huntingtons Disease
Current Pharmaceutical Design

Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
Current Neuropharmacology

Subject Index to Volume 3
Current Medicinal Chemistry - Central Nervous System Agents

Adult Neural Stem Cell Therapy: Expansion In Vitro, Tracking In Vivo and Clinical Transplantation
Current Drug Targets

Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases
Current Medicinal Chemistry

Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)

Systemic Redox Biomarkers in Neurodegenerative Diseases
Current Drug Metabolism

Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series
Current Drug Safety

Melatonin as Antioxidant Under Pathological Processes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)

Neurological Soft Signs in Patients with Psychosis and Cannabis Abuse: A Systematic Review and Meta-Analysis of Paradox
Current Pharmaceutical Design

Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape
Current Neuropharmacology

Pharmacodynamics of Memantine: An Update
Current Neuropharmacology

Attention Deficit and Hyperactivity Disorder: Controversies of Diagnosis and Safety of Pharmacological and Nonpharmacological Treatment
Current Drug Safety

5-HT2 Receptors
Current Drug Targets - CNS & Neurological Disorders

Anti-NMDA Receptor Encephalitis in Psychiatry
Current Psychiatry Reviews

Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
Current Neuropharmacology

New Ways of Detecting ADRs in Neonates and Children
Current Pharmaceutical Design

© 2025 Bentham Science Publishers | Privacy Policy